Clinical trials: in Albania
Partial Edentulism in the Maxilla or in the Mandible, Immediate Implant Placement
Comparing 7 mm and 5 mm Implants Placed Immediately After Molar Extraction
This clinical study aims to evaluate the performance and long-term outcomes of immediate dental implants placed in molar sites after tooth extraction.
- Trial name
- NCT07041294
- Testing
- 7 mm Diameter Dental Implant, 5 mm Diameter Dental Implant
- Where
- Albania
- Volunteers
- 70 people
- Sponsor
- Marco Esposito
Focus of Study: Tailored Implementation
PIECES - Towards Large-Scale Adaptation and Tailored Implementation of Primary Cancer Prevention Programs
The PIECES project aims to evaluate the Primary Cancer Prevention Implementation Toolkit (PCP-IT), an online implementation support toolkit that aids implementation teams in improving the implementation of primary cancer…
- Trial name
- PIECES (NCT06718322)
- Testing
- Primary Cancer Prevention Implementation Toolkit (PCP-IT)
- Where
- 11 sites in Albania, Australia and 7 more
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Hidde van der Ploeg
Renal Cell Cancer Metastatic, Kidney Cancer
Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-associated Fatigue
Fatigue is a prevalent adverse event associated with systemic therapy using tyrosine kinase inhibitors (TKIs). Meldonium, a fatty acid oxidation inhibitor, modifies the carnitine pathway, a nutrient critical for fat metabolism.
- Conditions
- Renal Cell Cancer Metastatic, Kidney Cancer, Fatigue Related to Cancer Treatment
- Trial name
- NCT06648902
- Testing
- meldonium
- Where
- 3 sites in Albania, Azerbaijan and 1 more
- Volunteers
- 60 people
- Sponsor
- Kidney Cancer Research Bureau
Cancer, Survivorship
Validation of the European Oncology Quality of Life Toolkit
The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship…
- Conditions
- Cancer, Survivorship, Palliative Care
- Trial name
- NCT05947903
- Testing
- Administration of the EUonQoL-Kit - Active Treatment questionnaire, Administration of the EUonQoL-Kit - Survivors questionnaire, Administration of the EUonQoL-Kit - Palliative Care questionnaire
- Where
- 45 sites in Albania, Austria and 30 more
- Volunteers
- 4,000 people
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Facial Skin Wrinkles
Safety And Efficacy Investigation Of The Effects Of ClearLift Q-Switched Nd:Yag 1064nm Laser Module In The Treatment Of Facial Skin Wrinkles
Alma Lasers ClearLift is a fractional non-ablative Q-Switched laser, allowing practitioners to use the benefits of a high intensity QS laser for the treatment of aged skin.
- Trial name
- NCT06349096
- Testing
- Alma Harmony
- Where
- Albania
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- Alma Lasers
Uterine Adenomyosis, Recurrent Implantation Failure
Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis
With this study the investigators want to test which is the best medical treatment for symptomatic adenomyosis affecting women undergoing IVF and with previous implantation failure, between Aromatase inhibitor plus GnRH analog…
- Conditions
- Uterine Adenomyosis, Recurrent Implantation Failure, Menstrual Pain
- Trial name
- NCT03421639
- Testing
- GnRH analog (11.25mg Leuprolide acetate), Aromatase inhibitor and GnRH analog, Aromatase and GnRH analog (11.25mg Leuprolide acetate)
- Where
- 3 sites in Albania, Bulgaria and 1 more
- Volunteers
- 300 people, healthy volunteers welcome
- Sponsor
- Centre for Endocrinology and Reproductive Medicine, Italy
Endometriosis
Degarelix in the Treatment of Endometriosis Recurrence
The long acting GnRH antagonist degarelix will be tested for the treatment of women with endometriosis recurrence compared with classical GnRH analog treatment.
- Trial name
- NCT01712763
- Testing
- degarelix, Leuprolide Acetate 11.25 MG/ML (Enantone 11,25)
- Where
- 3 sites in Albania, Bulgaria and 1 more
- Volunteers
- 360 people
- Sponsor
- Centre for Endocrinology and Reproductive Medicine, Italy
Ulcerative Colitis
Phase 2 Dose-finding IMU-838 for Ulcerative Colitis
This is a phase 2, multicenter, randomized, double-blind, placebo-controlled, dose-finding study to evaluate the efficacy and safety of IMU-838 for induction and maintenance therapy with an option for open-label treatment…
- Trial name
- CALDOSE-1 (NCT03341962)
- Testing
- IMU-838
- Where
- 131 sites in United States, Albania and 17 more
- Volunteers
- 263 people
- Sponsor
- Immunic AG
Hospital-acquired Pneumonia, Ventilator Associated Pneumonia
HOspital NEtwork STudy - Preparation for a Randomized Evaluation of Anti-Pneumonia Strategies
Hospital Acquired and Ventilator Associated Pneumonia (HAP/VAP) pose a significant burden to patients admitted to the Intensive Care Unit (ICU).
- Trial name
- HONEST-PREPS (NCT05060718)
- Where
- 16 sites in Albania, Croatia and 5 more
- Volunteers
- 2,165 people
- Sponsor
- UMC Utrecht
Polycystic Ovary Syndrome
Ovarian Innervation Study in Patients With Polycystic Ovary Syndrome (PCOS)
Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder characterized by hyperandrogenism, insulin resistance, and ovulatory dysfunction.
- Trial name
- NCT05966571
- Testing
- Ovary Biopsie
- Where
- Albania
- Volunteers
- 50 people
- Sponsor
- Albanian University
Advanced or Recurrent Solid Tumors, Breast Neoplasm
Comparison of Safety and Clinical Benefit of Injections Subcutaneously Talazoparib Versus Oral Talazoparib in Patients With Solid Tumors
To assess the safety and efficacy of two forms of Talazoparib therapy (injections subcutaneously Talazoparib and oral form for the treatment in the equivalent therapeutics dose
- Trial name
- NCT03426254
- Testing
- Injections Subcutaneously Talazoparib, Oral capsules Talazoparib
- Where
- Albania
- Sponsor
- Center Trials & Treatment
Syncope
The Management of Transient Loss of Consciousness and Suspected Syncope in European Emergency Departments
Prospective multi centre cohort study examining the clinical presentation, diagnostic tests, and management of adult Emergency Department (ED) patients presenting with Transient Loss of Consciousness (TLOC) either…
- Trial name
- SEED (NCT05571254)
- Testing
- Data collection
- Where
- 57 sites in Albania, Austria and 16 more
- Volunteers
- 952 people
- Sponsor
- NHS Lothian
Nephritis, Hereditary, Hematuria-Nephropathy-Deafness Syndrome
Biomarker for Alport Syndrome (BioAlport)
International, multicenter, observational, longitudinal monitoring study to identify biomarker/s for Alport syndrome and to explore the clinical robustness, specificity, and long-term variability of these biomarker/s
- Trial name
- BioAlport (NCT02718027)
- Where
- 7 sites in Albania, Georgia and 5 more
- Volunteers
- 12 people
- Sponsor
- CENTOGENE GmbH Rostock
Hypomelanotic Macules, Facial Angiofibroma
Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)
International, multicenter, observational, longitudinal study to identify biomarker/s for Tuberous Sclerosis Complex and to explore the clinical robustness, specificity, and long´-term variability of these biomarker/s
- Conditions
- Hypomelanotic Macules, Facial Angiofibroma, Shagreen Patches, Ungual Fibromas
- Trial name
- TuScCom (NCT02654340)
- Where
- 8 sites in Albania, Egypt and 6 more
- Volunteers
- 20 people
- Sponsor
- CENTOGENE GmbH Rostock
Chronic Nasal Congestion, Lung Infection
Biomarker for Cystic Fibrosis
International, multicenter, observational, longitudinal study to identify biomarker/s for Cystic fibrosis and to explore the clinical robustness, specificity, and long-term variability of these biomarker/s
- Conditions
- Chronic Nasal Congestion, Lung Infection, Breathlessness, Clubbing Toes
- Trial name
- BioCyFi (NCT02710383)
- Where
- 5 sites in Albania, Georgia and 3 more
- Volunteers
- 54 people
- Sponsor
- CENTOGENE GmbH Rostock
Mental Illness, Stigmatization
European Study on the Attitude of Psychiatrists Towards Their Patients
Background: Many people think that people with mental disorders might be dangerous or unpredictable. These patients face various sources of disadvantages and experience discrimination on job interviews, in education, and housing.
- Trial name
- Eustigma (NCT04644978)
- Testing
- anonymous online survey
- Where
- 31 sites in Albania, Austria and 29 more
- Volunteers
- 4,245 people, healthy volunteers welcome
- Sponsor
- Semmelweis University
Metabolic Acidosis, Chronic Kidney Disease
Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis
The purpose of this study is to evaluate the effect of TRC101 on the progression of chronic kidney disease (CKD) and to evaluate the safety profile of TRC101 in CKD patients with metabolic acidosis.
- Trial name
- VALOR-CKD (NCT03710291)
- Testing
- TRC101
- Where
- 203 sites in United States, Albania and 32 more
- Volunteers
- 1,480 people
- Sponsor
- Tricida, Inc.
Complication of Surgical Procedure, Acute Respiratory Failure, Adult
Prospective Evaluation of a RIsk Score for Postoperative Pulmonary COmPlications in Europe
Prospective Evaluation of a RIsk Score for postoperative pulmonary COmPlications in Europe (PERISCOPE) is a multi-centre, international observational study of a random-sample cohort of patients undergoing a nonobstetric…
- Conditions
- Complication of Surgical Procedure, Acute Respiratory Failure, Adult, Postoperative Respiratory Complications, Pulmonary Failure
- Trial name
- PERISCOPE (NCT01346709)
- Where
- 63 sites in Albania, Belgium and 19 more
- Volunteers
- 5,450 people
- Sponsor
- European Society of Anaesthesiology
Genetic Disease
Metabolic FingerPrinting
The MetaPrint study aims to characterize the metabolic fingerprint of genetic diseases in order to enhance knowledge on the physiological disease status and establish so new tools for diagnosing, monitoring and personalizing…
- Trial name
- MetaPrint (NCT05305729)
- Testing
- No intervention
- Where
- 5 sites in Albania, Pakistan
- Volunteers
- 10,000 people
- Sponsor
- Arcensus GmbH
Increased Lordosis/Scoliosis, Hyporeflexia
Biomarker for Duchenne Muscular Dystrophy
International, multicenter, observational, longitudinal study to identify biomarker/s for Duchenne Muscular Dystropy (DMD) and to explore the clinical robustness, specificity, and long-term variability of these biomarker/s.
- Conditions
- Increased Lordosis/Scoliosis, Hyporeflexia, Duchenne Muscular Dystrophy, Red-Green Color Blindness
- Trial name
- BioDuchenne (NCT02994030)
- Where
- 12 sites in Albania, Egypt and 6 more
- Volunteers
- 103 people
- Sponsor
- CENTOGENE GmbH Rostock